Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Volkin

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Vaccine|May 17, 2017
Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidateAshaben Patel, Steven M Erb, Linda Strange, et al.
Journal of Pharmaceutical Sciences|September 4, 2018
Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability StudiesAshaben Patel, Vineet Gupta, John Hickey, et al.
Journal of Pharmaceutical Sciences|February 13, 2016
Production, Characterization, and Biological Evaluation of Well-Defined IgG1 Fc Glycoforms as a Model System for Biosimilarity AnalysisSolomon Z Okbazghi, Apurva S More, Derek R White, et al.
Clinical and Vaccine Immunology : CVI|October 13, 2017
High-Resolution Epitope Positioning of a Large Collection of Neutralizing and Nonneutralizing Single-Domain Antibodies on the Enzymatic and Binding Subunits of Ricin ToxinDavid J Vance, Jacqueline M Tremblay, Yinghui Rong, et al.
Journal of Pharmaceutical Sciences|December 30, 2009
Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibodyMichael D Bond, Mark E Panek, Zheru Zhang, et al.
Journal of Pharmaceutical Sciences|December 23, 2022
Measurement of Adenovirus-Based Vector HeterogeneityJohn M Hickey, Shaleem I Jacob, Andrew S Tait, et al.
Journal of Pharmaceutical Sciences|December 19, 2014
Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stressSrivalli Telikepalli, Ozan S Kumru, Jae Hyun Kim, et al.
Vaccines|June 27, 2024
Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation ChallengesPrashant Kumar, David A Holland, Kathryn Secrist, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell linesOzan S Kumru, Mrinmoy Sanyal, Natalia Friedland, et al.
Journal of Pharmaceutical Sciences|October 17, 2013
Development of a stable virus-like particle vaccine formulation against Chikungunya virus and investigation of the effects of polyanionsRyan M Kramer, Yuhong Zeng, Neha Sahni, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Vaccine|May 17, 2017
Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidateAshaben Patel, Steven M Erb, Linda Strange, et al.
Journal of Pharmaceutical Sciences|September 4, 2018
Coformulation of Broadly Neutralizing Antibodies 3BNC117 and PGT121: Analytical Challenges During Preformulation Characterization and Storage Stability StudiesAshaben Patel, Vineet Gupta, John Hickey, et al.
Journal of Pharmaceutical Sciences|February 13, 2016
Production, Characterization, and Biological Evaluation of Well-Defined IgG1 Fc Glycoforms as a Model System for Biosimilarity AnalysisSolomon Z Okbazghi, Apurva S More, Derek R White, et al.
Clinical and Vaccine Immunology : CVI|October 13, 2017
High-Resolution Epitope Positioning of a Large Collection of Neutralizing and Nonneutralizing Single-Domain Antibodies on the Enzymatic and Binding Subunits of Ricin ToxinDavid J Vance, Jacqueline M Tremblay, Yinghui Rong, et al.
Journal of Pharmaceutical Sciences|December 30, 2009
Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibodyMichael D Bond, Mark E Panek, Zheru Zhang, et al.
Journal of Pharmaceutical Sciences|December 23, 2022
Measurement of Adenovirus-Based Vector HeterogeneityJohn M Hickey, Shaleem I Jacob, Andrew S Tait, et al.
Journal of Pharmaceutical Sciences|December 19, 2014
Characterization of the physical stability of a lyophilized IgG1 mAb after accelerated shipping-like stressSrivalli Telikepalli, Ozan S Kumru, Jae Hyun Kim, et al.
Vaccines|June 27, 2024
Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation ChallengesPrashant Kumar, David A Holland, Kathryn Secrist, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell linesOzan S Kumru, Mrinmoy Sanyal, Natalia Friedland, et al.
Journal of Pharmaceutical Sciences|October 17, 2013
Development of a stable virus-like particle vaccine formulation against Chikungunya virus and investigation of the effects of polyanionsRyan M Kramer, Yuhong Zeng, Neha Sahni, et al.
Pageof 18